Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
December 2021 "3-part randomized, double-blind, placebo-controlled Phase 1 study will evaluate TRV045 safety, tolerability, and PK in...
top of page
Ecosystem
Beta Site
Blog: Blog2
GPCR News
Search
Become a Member
Individuals
Organizations